Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia

• Auteurs principaux: Nanjiba Nawaz MD (Auteur), Tyler Mistretta MD (Auteur), Christian Karime MD (Auteur), Jason Lewis MD (Auteur), Emily Wolf MD (Auteur)
• Format: Livre
• Publié: SAGE Publishing, 2024-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Niacin, an important component of a balanced diet, is central to lipid metabolism. Occasionally used to treat hyperlipidemia, niacin is widely available without a prescription, making its use often unknown to treating physicians. Severe hepatotoxicity has been reported with niacin use. In the follow...